Science & Technology
Sbir Concept Award-Nanosponge Linked Dclk1 Inhibitors for the Targeted Treatment of Cholangiocarcinoma
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N91023C00008
Award Ceiling
$353K
Award Floor
$353K
Close Date
N/A
Total Funding
$353K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N91023C00008
Description
SBIR Phase Phase I award: "SBIR CONCEPT AWARD-NANOSPONGE LINKED DCLK1 INHIBITORS FOR THE TARGETED TREATMENT OF CHOLANGIOCARCINOMA" awarded to DCLK1 LLC in KANSAS CITY, Missouri. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $353,412. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.